Is it growing?
Is AMRX growing?
Amneal Pharmaceuticals, Inc. has grown revenue 10% a year over three years and 8.9% a year over five.
+10%
Revenue growth, 3-year annual rate · Drug Manufacturers - Specialty & Generic median +15% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue
- Revenue growth, 5-year rate
- +8.9%
Revenue growth, 5-year rate · +10% over three · growth has picked up over the last three years
- Years of annual history on file
- 10
Years of annual history on file · FY2016 to FY2025, as filed
Details›
- Revenue FY2021
- $2.09B
- Revenue FY2022
- $2.21B
- Revenue FY2023
- $2.39B
- Revenue FY2024
- $2.79B
- Revenue FY2025
- $3.02B
Annual income statements as filed with the SEC.
Drug Manufacturers - Specialty & Generic
Ranks #22 of 28 by Smart Score